0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurokinin Receptor Antagonists API Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-34V18186
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Neurokinin Receptor Antagonists API Market Research Report 2024
BUY CHAPTERS

Global Neurokinin Receptor Antagonists API Market Research Report 2024

Code: QYRE-Auto-34V18186
Report
November 2024
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neurokinin Receptor Antagonists API Market

Neurokinin receptor antagonists API (active pharmaceutical ingredient) refers to the biologically active compounds that inhibit the action of neurokinins by blocking their respective receptors, primarily neurokinin-1 (NK1) and neurokinin-3 (NK3) receptors. These antagonists are designed to counteract the effects of neuropeptides such as substance P and neurokinin B, which are involved in various physiological processes, including the regulation of nausea, vomiting, pain perception, and mood.
The global Neurokinin Receptor Antagonists API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Neurokinin Receptor Antagonists API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neurokinin Receptor Antagonists API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Neurokinin Receptor Antagonists API include Dr. Reddy's Laboratories, Glenmark Life Sciences, Jubilant Pharmova, Murli Krishna Pharma, MSN Laboratories, Optimus Pharma, Piramal Pharma, Solara Active Pharma Sciences, Camus Pharma, Clearsynth Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurokinin Receptor Antagonists API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurokinin Receptor Antagonists API.
The Neurokinin Receptor Antagonists API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Neurokinin Receptor Antagonists API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurokinin Receptor Antagonists API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neurokinin Receptor Antagonists API Market Report

Report Metric Details
Report Name Neurokinin Receptor Antagonists API Market
Segment by Type
Segment by Application
  • Tablets
  • Capsules
  • Oral Suspension
  • Injections
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dr. Reddy's Laboratories, Glenmark Life Sciences, Jubilant Pharmova, Murli Krishna Pharma, MSN Laboratories, Optimus Pharma, Piramal Pharma, Solara Active Pharma Sciences, Camus Pharma, Clearsynth Labs, Helsinn Advanced Synthesis, Procos, Andenex, Taizhou Crene Biotechnology, Zydus Animal Health And Investments, Wisdom Pharmaceutical, Zhejiang Tiantai Pharmaceutical, Qilu Pharmaceutical, Kelun Pharmaceutical, Hansoh Pharma, Luoxin Pharmaceuticals, Hangzhou Jiuyuan Gene Engineering, Lianyungang Runzhong Pharmaceutical, Viwit, Humanwell Pharmaceutical, Shandong Anxin Pharmaceutical, Beijing Sjar Technology Development, Sichuan Qingmu Pharmaceutical, Shandong New Time Pharmaceutical, United Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurokinin Receptor Antagonists API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurokinin Receptor Antagonists API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Neurokinin Receptor Antagonists API Market report?

Ans: The main players in the Neurokinin Receptor Antagonists API Market are Dr. Reddy's Laboratories, Glenmark Life Sciences, Jubilant Pharmova, Murli Krishna Pharma, MSN Laboratories, Optimus Pharma, Piramal Pharma, Solara Active Pharma Sciences, Camus Pharma, Clearsynth Labs, Helsinn Advanced Synthesis, Procos, Andenex, Taizhou Crene Biotechnology, Zydus Animal Health And Investments, Wisdom Pharmaceutical, Zhejiang Tiantai Pharmaceutical, Qilu Pharmaceutical, Kelun Pharmaceutical, Hansoh Pharma, Luoxin Pharmaceuticals, Hangzhou Jiuyuan Gene Engineering, Lianyungang Runzhong Pharmaceutical, Viwit, Humanwell Pharmaceutical, Shandong Anxin Pharmaceutical, Beijing Sjar Technology Development, Sichuan Qingmu Pharmaceutical, Shandong New Time Pharmaceutical, United Pharma

What are the Application segmentation covered in the Neurokinin Receptor Antagonists API Market report?

Ans: The Applications covered in the Neurokinin Receptor Antagonists API Market report are Tablets, Capsules, Oral Suspension, Injections, Other

What are the Type segmentation covered in the Neurokinin Receptor Antagonists API Market report?

Ans: The Types covered in the Neurokinin Receptor Antagonists API Market report are Fezolinetant, Aprepitant, Rolapitant, Fosaprepitant, Netupitant, Maropitant

Recommended Reports

Receptor Antagonists

API Market Trends

Psychiatric & Therapeutic APIs

1 Neurokinin Receptor Antagonists API Market Overview
1.1 Product Definition
1.2 Neurokinin Receptor Antagonists API by Type
1.2.1 Global Neurokinin Receptor Antagonists API Market Value Comparison by Type (2024-2030)
1.2.2 Fezolinetant
1.2.3 Aprepitant
1.2.4 Rolapitant
1.2.5 Fosaprepitant
1.2.6 Netupitant
1.2.7 Maropitant
1.3 Neurokinin Receptor Antagonists API by Application
1.3.1 Global Neurokinin Receptor Antagonists API Market Value by Application (2024-2030)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Oral Suspension
1.3.5 Injections
1.3.6 Other
1.4 Global Neurokinin Receptor Antagonists API Market Size Estimates and Forecasts
1.4.1 Global Neurokinin Receptor Antagonists API Revenue 2019-2030
1.4.2 Global Neurokinin Receptor Antagonists API Sales 2019-2030
1.4.3 Global Neurokinin Receptor Antagonists API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurokinin Receptor Antagonists API Market Competition by Manufacturers
2.1 Global Neurokinin Receptor Antagonists API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurokinin Receptor Antagonists API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurokinin Receptor Antagonists API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Neurokinin Receptor Antagonists API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurokinin Receptor Antagonists API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurokinin Receptor Antagonists API, Product Type & Application
2.7 Global Key Manufacturers of Neurokinin Receptor Antagonists API, Date of Enter into This Industry
2.8 Global Neurokinin Receptor Antagonists API Market Competitive Situation and Trends
2.8.1 Global Neurokinin Receptor Antagonists API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neurokinin Receptor Antagonists API Players Market Share by Revenue
2.8.3 Global Neurokinin Receptor Antagonists API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurokinin Receptor Antagonists API Market Scenario by Region
3.1 Global Neurokinin Receptor Antagonists API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurokinin Receptor Antagonists API Sales by Region: 2019-2030
3.2.1 Global Neurokinin Receptor Antagonists API Sales by Region: 2019-2024
3.2.2 Global Neurokinin Receptor Antagonists API Sales by Region: 2025-2030
3.3 Global Neurokinin Receptor Antagonists API Revenue by Region: 2019-2030
3.3.1 Global Neurokinin Receptor Antagonists API Revenue by Region: 2019-2024
3.3.2 Global Neurokinin Receptor Antagonists API Revenue by Region: 2025-2030
3.4 North America Neurokinin Receptor Antagonists API Market Facts & Figures by Country
3.4.1 North America Neurokinin Receptor Antagonists API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurokinin Receptor Antagonists API Sales by Country (2019-2030)
3.4.3 North America Neurokinin Receptor Antagonists API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurokinin Receptor Antagonists API Market Facts & Figures by Country
3.5.1 Europe Neurokinin Receptor Antagonists API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurokinin Receptor Antagonists API Sales by Country (2019-2030)
3.5.3 Europe Neurokinin Receptor Antagonists API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurokinin Receptor Antagonists API Market Facts & Figures by Region
3.6.1 Asia Pacific Neurokinin Receptor Antagonists API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurokinin Receptor Antagonists API Sales by Region (2019-2030)
3.6.3 Asia Pacific Neurokinin Receptor Antagonists API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurokinin Receptor Antagonists API Market Facts & Figures by Country
3.7.1 Latin America Neurokinin Receptor Antagonists API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurokinin Receptor Antagonists API Sales by Country (2019-2030)
3.7.3 Latin America Neurokinin Receptor Antagonists API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Neurokinin Receptor Antagonists API Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurokinin Receptor Antagonists API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurokinin Receptor Antagonists API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurokinin Receptor Antagonists API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurokinin Receptor Antagonists API Sales by Type (2019-2030)
4.1.1 Global Neurokinin Receptor Antagonists API Sales by Type (2019-2024)
4.1.2 Global Neurokinin Receptor Antagonists API Sales by Type (2025-2030)
4.1.3 Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2019-2030)
4.2 Global Neurokinin Receptor Antagonists API Revenue by Type (2019-2030)
4.2.1 Global Neurokinin Receptor Antagonists API Revenue by Type (2019-2024)
4.2.2 Global Neurokinin Receptor Antagonists API Revenue by Type (2025-2030)
4.2.3 Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2019-2030)
4.3 Global Neurokinin Receptor Antagonists API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurokinin Receptor Antagonists API Sales by Application (2019-2030)
5.1.1 Global Neurokinin Receptor Antagonists API Sales by Application (2019-2024)
5.1.2 Global Neurokinin Receptor Antagonists API Sales by Application (2025-2030)
5.1.3 Global Neurokinin Receptor Antagonists API Sales Market Share by Application (2019-2030)
5.2 Global Neurokinin Receptor Antagonists API Revenue by Application (2019-2030)
5.2.1 Global Neurokinin Receptor Antagonists API Revenue by Application (2019-2024)
5.2.2 Global Neurokinin Receptor Antagonists API Revenue by Application (2025-2030)
5.2.3 Global Neurokinin Receptor Antagonists API Revenue Market Share by Application (2019-2030)
5.3 Global Neurokinin Receptor Antagonists API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dr. Reddy's Laboratories
6.1.1 Dr. Reddy's Laboratories Company Information
6.1.2 Dr. Reddy's Laboratories Description and Business Overview
6.1.3 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolio
6.1.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.2 Glenmark Life Sciences
6.2.1 Glenmark Life Sciences Company Information
6.2.2 Glenmark Life Sciences Description and Business Overview
6.2.3 Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolio
6.2.5 Glenmark Life Sciences Recent Developments/Updates
6.3 Jubilant Pharmova
6.3.1 Jubilant Pharmova Company Information
6.3.2 Jubilant Pharmova Description and Business Overview
6.3.3 Jubilant Pharmova Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolio
6.3.5 Jubilant Pharmova Recent Developments/Updates
6.4 Murli Krishna Pharma
6.4.1 Murli Krishna Pharma Company Information
6.4.2 Murli Krishna Pharma Description and Business Overview
6.4.3 Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolio
6.4.5 Murli Krishna Pharma Recent Developments/Updates
6.5 MSN Laboratories
6.5.1 MSN Laboratories Company Information
6.5.2 MSN Laboratories Description and Business Overview
6.5.3 MSN Laboratories Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolio
6.5.5 MSN Laboratories Recent Developments/Updates
6.6 Optimus Pharma
6.6.1 Optimus Pharma Company Information
6.6.2 Optimus Pharma Description and Business Overview
6.6.3 Optimus Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolio
6.6.5 Optimus Pharma Recent Developments/Updates
6.7 Piramal Pharma
6.7.1 Piramal Pharma Company Information
6.7.2 Piramal Pharma Description and Business Overview
6.7.3 Piramal Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolio
6.7.5 Piramal Pharma Recent Developments/Updates
6.8 Solara Active Pharma Sciences
6.8.1 Solara Active Pharma Sciences Company Information
6.8.2 Solara Active Pharma Sciences Description and Business Overview
6.8.3 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolio
6.8.5 Solara Active Pharma Sciences Recent Developments/Updates
6.9 Camus Pharma
6.9.1 Camus Pharma Company Information
6.9.2 Camus Pharma Description and Business Overview
6.9.3 Camus Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Camus Pharma Neurokinin Receptor Antagonists API Product Portfolio
6.9.5 Camus Pharma Recent Developments/Updates
6.10 Clearsynth Labs
6.10.1 Clearsynth Labs Company Information
6.10.2 Clearsynth Labs Description and Business Overview
6.10.3 Clearsynth Labs Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolio
6.10.5 Clearsynth Labs Recent Developments/Updates
6.11 Helsinn Advanced Synthesis
6.11.1 Helsinn Advanced Synthesis Company Information
6.11.2 Helsinn Advanced Synthesis Description and Business Overview
6.11.3 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolio
6.11.5 Helsinn Advanced Synthesis Recent Developments/Updates
6.12 Procos
6.12.1 Procos Company Information
6.12.2 Procos Description and Business Overview
6.12.3 Procos Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Procos Neurokinin Receptor Antagonists API Product Portfolio
6.12.5 Procos Recent Developments/Updates
6.13 Andenex
6.13.1 Andenex Company Information
6.13.2 Andenex Description and Business Overview
6.13.3 Andenex Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Andenex Neurokinin Receptor Antagonists API Product Portfolio
6.13.5 Andenex Recent Developments/Updates
6.14 Taizhou Crene Biotechnology
6.14.1 Taizhou Crene Biotechnology Company Information
6.14.2 Taizhou Crene Biotechnology Description and Business Overview
6.14.3 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolio
6.14.5 Taizhou Crene Biotechnology Recent Developments/Updates
6.15 Zydus Animal Health And Investments
6.15.1 Zydus Animal Health And Investments Company Information
6.15.2 Zydus Animal Health And Investments Description and Business Overview
6.15.3 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolio
6.15.5 Zydus Animal Health And Investments Recent Developments/Updates
6.16 Wisdom Pharmaceutical
6.16.1 Wisdom Pharmaceutical Company Information
6.16.2 Wisdom Pharmaceutical Description and Business Overview
6.16.3 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.16.5 Wisdom Pharmaceutical Recent Developments/Updates
6.17 Zhejiang Tiantai Pharmaceutical
6.17.1 Zhejiang Tiantai Pharmaceutical Company Information
6.17.2 Zhejiang Tiantai Pharmaceutical Description and Business Overview
6.17.3 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.17.5 Zhejiang Tiantai Pharmaceutical Recent Developments/Updates
6.18 Qilu Pharmaceutical
6.18.1 Qilu Pharmaceutical Company Information
6.18.2 Qilu Pharmaceutical Description and Business Overview
6.18.3 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.18.5 Qilu Pharmaceutical Recent Developments/Updates
6.19 Kelun Pharmaceutical
6.19.1 Kelun Pharmaceutical Company Information
6.19.2 Kelun Pharmaceutical Description and Business Overview
6.19.3 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.19.5 Kelun Pharmaceutical Recent Developments/Updates
6.20 Hansoh Pharma
6.20.1 Hansoh Pharma Company Information
6.20.2 Hansoh Pharma Description and Business Overview
6.20.3 Hansoh Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolio
6.20.5 Hansoh Pharma Recent Developments/Updates
6.21 Luoxin Pharmaceuticals
6.21.1 Luoxin Pharmaceuticals Company Information
6.21.2 Luoxin Pharmaceuticals Description and Business Overview
6.21.3 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolio
6.21.5 Luoxin Pharmaceuticals Recent Developments/Updates
6.22 Hangzhou Jiuyuan Gene Engineering
6.22.1 Hangzhou Jiuyuan Gene Engineering Company Information
6.22.2 Hangzhou Jiuyuan Gene Engineering Description and Business Overview
6.22.3 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolio
6.22.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
6.23 Lianyungang Runzhong Pharmaceutical
6.23.1 Lianyungang Runzhong Pharmaceutical Company Information
6.23.2 Lianyungang Runzhong Pharmaceutical Description and Business Overview
6.23.3 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.23.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
6.24 Viwit
6.24.1 Viwit Company Information
6.24.2 Viwit Description and Business Overview
6.24.3 Viwit Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Viwit Neurokinin Receptor Antagonists API Product Portfolio
6.24.5 Viwit Recent Developments/Updates
6.25 Humanwell Pharmaceutical
6.25.1 Humanwell Pharmaceutical Company Information
6.25.2 Humanwell Pharmaceutical Description and Business Overview
6.25.3 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.25.5 Humanwell Pharmaceutical Recent Developments/Updates
6.26 Shandong Anxin Pharmaceutical
6.26.1 Shandong Anxin Pharmaceutical Company Information
6.26.2 Shandong Anxin Pharmaceutical Description and Business Overview
6.26.3 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.26.5 Shandong Anxin Pharmaceutical Recent Developments/Updates
6.27 Beijing Sjar Technology Development
6.27.1 Beijing Sjar Technology Development Company Information
6.27.2 Beijing Sjar Technology Development Description and Business Overview
6.27.3 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolio
6.27.5 Beijing Sjar Technology Development Recent Developments/Updates
6.28 Sichuan Qingmu Pharmaceutical
6.28.1 Sichuan Qingmu Pharmaceutical Company Information
6.28.2 Sichuan Qingmu Pharmaceutical Description and Business Overview
6.28.3 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.28.4 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.28.5 Sichuan Qingmu Pharmaceutical Recent Developments/Updates
6.29 Shandong New Time Pharmaceutical
6.29.1 Shandong New Time Pharmaceutical Company Information
6.29.2 Shandong New Time Pharmaceutical Description and Business Overview
6.29.3 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.29.4 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
6.29.5 Shandong New Time Pharmaceutical Recent Developments/Updates
6.30 United Pharma
6.30.1 United Pharma Company Information
6.30.2 United Pharma Description and Business Overview
6.30.3 United Pharma Neurokinin Receptor Antagonists API Sales, Revenue and Gross Margin (2019-2024)
6.30.4 United Pharma Neurokinin Receptor Antagonists API Product Portfolio
6.30.5 United Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurokinin Receptor Antagonists API Industry Chain Analysis
7.2 Neurokinin Receptor Antagonists API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurokinin Receptor Antagonists API Production Mode & Process
7.4 Neurokinin Receptor Antagonists API Sales and Marketing
7.4.1 Neurokinin Receptor Antagonists API Sales Channels
7.4.2 Neurokinin Receptor Antagonists API Distributors
7.5 Neurokinin Receptor Antagonists API Customers
8 Neurokinin Receptor Antagonists API Market Dynamics
8.1 Neurokinin Receptor Antagonists API Industry Trends
8.2 Neurokinin Receptor Antagonists API Market Drivers
8.3 Neurokinin Receptor Antagonists API Market Challenges
8.4 Neurokinin Receptor Antagonists API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Neurokinin Receptor Antagonists API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Neurokinin Receptor Antagonists API Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Neurokinin Receptor Antagonists API Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Neurokinin Receptor Antagonists API Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Neurokinin Receptor Antagonists API Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Neurokinin Receptor Antagonists API Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Neurokinin Receptor Antagonists API Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Neurokinin Receptor Antagonists API Average Price (US$/kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Neurokinin Receptor Antagonists API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Neurokinin Receptor Antagonists API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Neurokinin Receptor Antagonists API, Product Type & Application
 Table 12. Global Key Manufacturers of Neurokinin Receptor Antagonists API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Neurokinin Receptor Antagonists API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurokinin Receptor Antagonists API as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Neurokinin Receptor Antagonists API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Neurokinin Receptor Antagonists API Sales by Region (2019-2024) & (Tons)
 Table 18. Global Neurokinin Receptor Antagonists API Sales Market Share by Region (2019-2024)
 Table 19. Global Neurokinin Receptor Antagonists API Sales by Region (2025-2030) & (Tons)
 Table 20. Global Neurokinin Receptor Antagonists API Sales Market Share by Region (2025-2030)
 Table 21. Global Neurokinin Receptor Antagonists API Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Neurokinin Receptor Antagonists API Revenue Market Share by Region (2019-2024)
 Table 23. Global Neurokinin Receptor Antagonists API Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Neurokinin Receptor Antagonists API Revenue Market Share by Region (2025-2030)
 Table 25. North America Neurokinin Receptor Antagonists API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Neurokinin Receptor Antagonists API Sales by Country (2019-2024) & (Tons)
 Table 27. North America Neurokinin Receptor Antagonists API Sales by Country (2025-2030) & (Tons)
 Table 28. North America Neurokinin Receptor Antagonists API Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Neurokinin Receptor Antagonists API Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Neurokinin Receptor Antagonists API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Neurokinin Receptor Antagonists API Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Neurokinin Receptor Antagonists API Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Neurokinin Receptor Antagonists API Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Neurokinin Receptor Antagonists API Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Neurokinin Receptor Antagonists API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Neurokinin Receptor Antagonists API Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Neurokinin Receptor Antagonists API Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Neurokinin Receptor Antagonists API Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Neurokinin Receptor Antagonists API Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Neurokinin Receptor Antagonists API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Neurokinin Receptor Antagonists API Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Neurokinin Receptor Antagonists API Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Neurokinin Receptor Antagonists API Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Neurokinin Receptor Antagonists API Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Neurokinin Receptor Antagonists API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Neurokinin Receptor Antagonists API Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Neurokinin Receptor Antagonists API Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Neurokinin Receptor Antagonists API Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Neurokinin Receptor Antagonists API Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Neurokinin Receptor Antagonists API Sales (Tons) by Type (2019-2024)
 Table 51. Global Neurokinin Receptor Antagonists API Sales (Tons) by Type (2025-2030)
 Table 52. Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2019-2024)
 Table 53. Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2025-2030)
 Table 54. Global Neurokinin Receptor Antagonists API Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Neurokinin Receptor Antagonists API Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2019-2024)
 Table 57. Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2025-2030)
 Table 58. Global Neurokinin Receptor Antagonists API Price (US$/kg) by Type (2019-2024)
 Table 59. Global Neurokinin Receptor Antagonists API Price (US$/kg) by Type (2025-2030)
 Table 60. Global Neurokinin Receptor Antagonists API Sales (Tons) by Application (2019-2024)
 Table 61. Global Neurokinin Receptor Antagonists API Sales (Tons) by Application (2025-2030)
 Table 62. Global Neurokinin Receptor Antagonists API Sales Market Share by Application (2019-2024)
 Table 63. Global Neurokinin Receptor Antagonists API Sales Market Share by Application (2025-2030)
 Table 64. Global Neurokinin Receptor Antagonists API Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Neurokinin Receptor Antagonists API Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Neurokinin Receptor Antagonists API Revenue Market Share by Application (2019-2024)
 Table 67. Global Neurokinin Receptor Antagonists API Revenue Market Share by Application (2025-2030)
 Table 68. Global Neurokinin Receptor Antagonists API Price (US$/kg) by Application (2019-2024)
 Table 69. Global Neurokinin Receptor Antagonists API Price (US$/kg) by Application (2025-2030)
 Table 70. Dr. Reddy's Laboratories Company Information
 Table 71. Dr. Reddy's Laboratories Description and Business Overview
 Table 72. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 73. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product
 Table 74. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 75. Glenmark Life Sciences Company Information
 Table 76. Glenmark Life Sciences Description and Business Overview
 Table 77. Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 78. Glenmark Life Sciences Neurokinin Receptor Antagonists API Product
 Table 79. Glenmark Life Sciences Recent Developments/Updates
 Table 80. Jubilant Pharmova Company Information
 Table 81. Jubilant Pharmova Description and Business Overview
 Table 82. Jubilant Pharmova Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 83. Jubilant Pharmova Neurokinin Receptor Antagonists API Product
 Table 84. Jubilant Pharmova Recent Developments/Updates
 Table 85. Murli Krishna Pharma Company Information
 Table 86. Murli Krishna Pharma Description and Business Overview
 Table 87. Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 88. Murli Krishna Pharma Neurokinin Receptor Antagonists API Product
 Table 89. Murli Krishna Pharma Recent Developments/Updates
 Table 90. MSN Laboratories Company Information
 Table 91. MSN Laboratories Description and Business Overview
 Table 92. MSN Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 93. MSN Laboratories Neurokinin Receptor Antagonists API Product
 Table 94. MSN Laboratories Recent Developments/Updates
 Table 95. Optimus Pharma Company Information
 Table 96. Optimus Pharma Description and Business Overview
 Table 97. Optimus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 98. Optimus Pharma Neurokinin Receptor Antagonists API Product
 Table 99. Optimus Pharma Recent Developments/Updates
 Table 100. Piramal Pharma Company Information
 Table 101. Piramal Pharma Description and Business Overview
 Table 102. Piramal Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 103. Piramal Pharma Neurokinin Receptor Antagonists API Product
 Table 104. Piramal Pharma Recent Developments/Updates
 Table 105. Solara Active Pharma Sciences Company Information
 Table 106. Solara Active Pharma Sciences Description and Business Overview
 Table 107. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 108. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product
 Table 109. Solara Active Pharma Sciences Recent Developments/Updates
 Table 110. Camus Pharma Company Information
 Table 111. Camus Pharma Description and Business Overview
 Table 112. Camus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 113. Camus Pharma Neurokinin Receptor Antagonists API Product
 Table 114. Camus Pharma Recent Developments/Updates
 Table 115. Clearsynth Labs Company Information
 Table 116. Clearsynth Labs Description and Business Overview
 Table 117. Clearsynth Labs Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 118. Clearsynth Labs Neurokinin Receptor Antagonists API Product
 Table 119. Clearsynth Labs Recent Developments/Updates
 Table 120. Helsinn Advanced Synthesis Company Information
 Table 121. Helsinn Advanced Synthesis Description and Business Overview
 Table 122. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 123. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product
 Table 124. Helsinn Advanced Synthesis Recent Developments/Updates
 Table 125. Procos Company Information
 Table 126. Procos Description and Business Overview
 Table 127. Procos Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 128. Procos Neurokinin Receptor Antagonists API Product
 Table 129. Procos Recent Developments/Updates
 Table 130. Andenex Company Information
 Table 131. Andenex Description and Business Overview
 Table 132. Andenex Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 133. Andenex Neurokinin Receptor Antagonists API Product
 Table 134. Andenex Recent Developments/Updates
 Table 135. Taizhou Crene Biotechnology Company Information
 Table 136. Taizhou Crene Biotechnology Description and Business Overview
 Table 137. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 138. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product
 Table 139. Taizhou Crene Biotechnology Recent Developments/Updates
 Table 140. Zydus Animal Health And Investments Company Information
 Table 141. Zydus Animal Health And Investments Description and Business Overview
 Table 142. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 143. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product
 Table 144. Zydus Animal Health And Investments Recent Developments/Updates
 Table 145. Wisdom Pharmaceutical Company Information
 Table 146. Wisdom Pharmaceutical Description and Business Overview
 Table 147. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 148. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 149. Wisdom Pharmaceutical Recent Developments/Updates
 Table 150. Zhejiang Tiantai Pharmaceutical Company Information
 Table 151. Zhejiang Tiantai Pharmaceutical Description and Business Overview
 Table 152. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 153. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 154. Zhejiang Tiantai Pharmaceutical Recent Developments/Updates
 Table 155. Qilu Pharmaceutical Company Information
 Table 156. Qilu Pharmaceutical Description and Business Overview
 Table 157. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 158. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 159. Qilu Pharmaceutical Recent Developments/Updates
 Table 160. Kelun Pharmaceutical Company Information
 Table 161. Kelun Pharmaceutical Description and Business Overview
 Table 162. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 163. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 164. Kelun Pharmaceutical Recent Developments/Updates
 Table 165. Hansoh Pharma Company Information
 Table 166. Hansoh Pharma Description and Business Overview
 Table 167. Hansoh Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 168. Hansoh Pharma Neurokinin Receptor Antagonists API Product
 Table 169. Hansoh Pharma Recent Developments/Updates
 Table 170. Luoxin Pharmaceuticals Company Information
 Table 171. Luoxin Pharmaceuticals Description and Business Overview
 Table 172. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 173. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product
 Table 174. Luoxin Pharmaceuticals Recent Developments/Updates
 Table 175. Hangzhou Jiuyuan Gene Engineering Company Information
 Table 176. Hangzhou Jiuyuan Gene Engineering Description and Business Overview
 Table 177. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 178. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product
 Table 179. Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
 Table 180. Lianyungang Runzhong Pharmaceutical Company Information
 Table 181. Lianyungang Runzhong Pharmaceutical Description and Business Overview
 Table 182. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 183. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 184. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
 Table 185. Viwit Company Information
 Table 186. Viwit Description and Business Overview
 Table 187. Viwit Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 188. Viwit Neurokinin Receptor Antagonists API Product
 Table 189. Viwit Recent Developments/Updates
 Table 190. Humanwell Pharmaceutical Company Information
 Table 191. Humanwell Pharmaceutical Description and Business Overview
 Table 192. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 193. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 194. Humanwell Pharmaceutical Recent Developments/Updates
 Table 195. Shandong Anxin Pharmaceutical Company Information
 Table 196. Shandong Anxin Pharmaceutical Description and Business Overview
 Table 197. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 198. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 199. Shandong Anxin Pharmaceutical Recent Developments/Updates
 Table 200. Beijing Sjar Technology Development Company Information
 Table 201. Beijing Sjar Technology Development Description and Business Overview
 Table 202. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 203. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product
 Table 204. Beijing Sjar Technology Development Recent Developments/Updates
 Table 205. Sichuan Qingmu Pharmaceutical Company Information
 Table 206. Sichuan Qingmu Pharmaceutical Description and Business Overview
 Table 207. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 208. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 209. Sichuan Qingmu Pharmaceutical Recent Developments/Updates
 Table 210. Shandong New Time Pharmaceutical Company Information
 Table 211. Shandong New Time Pharmaceutical Description and Business Overview
 Table 212. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 213. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product
 Table 214. Shandong New Time Pharmaceutical Recent Developments/Updates
 Table 215. United Pharma Company Information
 Table 216. United Pharma Description and Business Overview
 Table 217. United Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 218. United Pharma Neurokinin Receptor Antagonists API Product
 Table 219. United Pharma Recent Developments/Updates
 Table 220. Key Raw Materials Lists
 Table 221. Raw Materials Key Suppliers Lists
 Table 222. Neurokinin Receptor Antagonists API Distributors List
 Table 223. Neurokinin Receptor Antagonists API Customers List
 Table 224. Neurokinin Receptor Antagonists API Market Trends
 Table 225. Neurokinin Receptor Antagonists API Market Drivers
 Table 226. Neurokinin Receptor Antagonists API Market Challenges
 Table 227. Neurokinin Receptor Antagonists API Market Restraints
 Table 228. Research Programs/Design for This Report
 Table 229. Key Data Information from Secondary Sources
 Table 230. Key Data Information from Primary Sources
 Table 231. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Neurokinin Receptor Antagonists API
 Figure 2. Global Neurokinin Receptor Antagonists API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Neurokinin Receptor Antagonists API Market Share by Type: 2023 & 2030
 Figure 4. Fezolinetant Product Picture
 Figure 5. Aprepitant Product Picture
 Figure 6. Rolapitant Product Picture
 Figure 7. Fosaprepitant Product Picture
 Figure 8. Netupitant Product Picture
 Figure 9. Maropitant Product Picture
 Figure 10. Global Neurokinin Receptor Antagonists API Market Value by Application (2024-2030) & (US$ Million)
 Figure 11. Global Neurokinin Receptor Antagonists API Market Share by Application: 2023 & 2030
 Figure 12. Tablets
 Figure 13. Capsules
 Figure 14. Oral Suspension
 Figure 15. Injections
 Figure 16. Other
 Figure 17. Global Neurokinin Receptor Antagonists API Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 18. Global Neurokinin Receptor Antagonists API Market Size (2019-2030) & (US$ Million)
 Figure 19. Global Neurokinin Receptor Antagonists API Sales (2019-2030) & (Tons)
 Figure 20. Global Neurokinin Receptor Antagonists API Average Price (US$/kg) & (2019-2030)
 Figure 21. Neurokinin Receptor Antagonists API Report Years Considered
 Figure 22. Neurokinin Receptor Antagonists API Sales Share by Manufacturers in 2023
 Figure 23. Global Neurokinin Receptor Antagonists API Revenue Share by Manufacturers in 2023
 Figure 24. Global 5 and 10 Largest Neurokinin Receptor Antagonists API Players: Market Share by Revenue in Neurokinin Receptor Antagonists API in 2023
 Figure 25. Neurokinin Receptor Antagonists API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 26. Global Neurokinin Receptor Antagonists API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 27. North America Neurokinin Receptor Antagonists API Sales Market Share by Country (2019-2030)
 Figure 28. North America Neurokinin Receptor Antagonists API Revenue Market Share by Country (2019-2030)
 Figure 29. United States Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Canada Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Europe Neurokinin Receptor Antagonists API Sales Market Share by Country (2019-2030)
 Figure 32. Europe Neurokinin Receptor Antagonists API Revenue Market Share by Country (2019-2030)
 Figure 33. Germany Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. France Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. U.K. Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Italy Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Russia Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Asia Pacific Neurokinin Receptor Antagonists API Sales Market Share by Region (2019-2030)
 Figure 39. Asia Pacific Neurokinin Receptor Antagonists API Revenue Market Share by Region (2019-2030)
 Figure 40. China Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Japan Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. South Korea Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. India Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Australia Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. China Taiwan Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Southeast Asia Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Latin America Neurokinin Receptor Antagonists API Sales Market Share by Country (2019-2030)
 Figure 48. Mexico Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Brazil Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Argentina Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Colombia Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Middle East and Africa Neurokinin Receptor Antagonists API Sales Market Share by Country (2019-2030)
 Figure 53. Middle East and Africa Neurokinin Receptor Antagonists API Revenue Market Share by Country (2019-2030)
 Figure 54. Turkey Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Saudi Arabia Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. UAE Neurokinin Receptor Antagonists API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. Global Sales Market Share of Neurokinin Receptor Antagonists API by Type (2019-2030)
 Figure 58. Global Revenue Market Share of Neurokinin Receptor Antagonists API by Type (2019-2030)
 Figure 59. Global Neurokinin Receptor Antagonists API Price (US$/kg) by Type (2019-2030)
 Figure 60. Global Sales Market Share of Neurokinin Receptor Antagonists API by Application (2019-2030)
 Figure 61. Global Revenue Market Share of Neurokinin Receptor Antagonists API by Application (2019-2030)
 Figure 62. Global Neurokinin Receptor Antagonists API Price (US$/kg) by Application (2019-2030)
 Figure 63. Neurokinin Receptor Antagonists API Value Chain
 Figure 64. Neurokinin Receptor Antagonists API Production Process
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture